Buy ABCL by Aug 3, 2026.

# ABCL Before May 11 Earnings: The AI Antibody Discovery Bag Is Finally Entering Catalyst Season Three years ago I posted about AbCellera as an AI-powered antibody discovery company that Wall Street was sleeping on. Back then, the bull case was mostly platform, partnerships, cash, and the hope that the COVID antibody success was proof the engine worked. The stock got smoked after that, and fair enough, because “cool platform” does not pay you unless molecules actually move toward patients[.](https://imgur.com/a/B6Ivc9C) …